151 related articles for article (PubMed ID: 35952844)
1. Novel benzoxazinone derivative as potent human neutrophil elastase inhibitor: Potential implications in lung injury.
Sengupta S; Reddy JR; Rajesh N; Jaiswal A; Mabalirajan U; Palakodety RK; Mukherjee P; Bandyopadhyay A
Eur J Pharmacol; 2022 Sep; 931():175187. PubMed ID: 35952844
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of benzoxazinone derivatives on activity of human neutrophil elastase and on hemorrhagic shock-induced lung injury in rats.
Hsieh PW; Yu HP; Chang YJ; Hwang TL
Eur J Med Chem; 2010 Jul; 45(7):3111-5. PubMed ID: 20417587
[TBL] [Abstract][Full Text] [Related]
3. The potential of neutrophil elastase inhibitors as anti-inflammatory therapies.
Henriksen PA
Curr Opin Hematol; 2014 Jan; 21(1):23-8. PubMed ID: 24241342
[TBL] [Abstract][Full Text] [Related]
4. Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis.
Song JS; Kang CM; Rhee CK; Yoon HK; Kim YK; Moon HS; Park SH
Exp Lung Res; 2009 Dec; 35(10):817-29. PubMed ID: 19995276
[TBL] [Abstract][Full Text] [Related]
5. Effects of a synthetic protease inhibitor (gabexate mesilate) and a neutrophil elastase inhibitor (sivelestat sodium) on acid-induced lung injury in rats.
Yoshikawa S; Tsushima K; Koizumi T; Kubo K
Eur J Pharmacol; 2010 Sep; 641(2-3):220-5. PubMed ID: 20542026
[TBL] [Abstract][Full Text] [Related]
6. AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastase.
Stevens T; Ekholm K; Gränse M; Lindahl M; Kozma V; Jungar C; Ottosson T; Falk-Håkansson H; Churg A; Wright JL; Lal H; Sanfridson A
J Pharmacol Exp Ther; 2011 Oct; 339(1):313-20. PubMed ID: 21791628
[TBL] [Abstract][Full Text] [Related]
7. A neutrophil elastase inhibitor improves lung function during ex vivo lung perfusion.
Harada M; Oto T; Otani S; Miyoshi K; Okada M; Iga N; Nishikawa H; Sugimoto S; Yamane M; Miyoshi S
Gen Thorac Cardiovasc Surg; 2015 Dec; 63(12):645-51. PubMed ID: 26346003
[TBL] [Abstract][Full Text] [Related]
8. Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors.
Dau T; Sarker RS; Yildirim AO; Eickelberg O; Jenne DE
Nat Commun; 2015 Apr; 6():6722. PubMed ID: 25857284
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil elastase inhibitors.
Groutas WC; Dou D; Alliston KR
Expert Opin Ther Pat; 2011 Mar; 21(3):339-54. PubMed ID: 21235378
[TBL] [Abstract][Full Text] [Related]
10. Targeting COPD: advances on low-molecular-weight inhibitors of human neutrophil elastase.
Lucas SD; Costa E; Guedes RC; Moreira R
Med Res Rev; 2013 Jun; 33 Suppl 1():E73-101. PubMed ID: 21681767
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of neutrophil elastase attenuates gut mucosal injury evoked by acute alveolar hypoxia in rabbits.
Nakamura N; Morisaki H; Suzuki T; Yajima S; Katori N; Kotake Y; Funakoshi Y; Kawabata K; Yamada S; Ishizaka A; Takeda J
Shock; 2007 Jul; 28(1):101-5. PubMed ID: 17483739
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil elastase inhibitor prevents ischemic brain damage via reduction of vasogenic edema.
Ikegame Y; Yamashita K; Hayashi S; Yoshimura S; Nakashima S; Iwama T
Hypertens Res; 2010 Jul; 33(7):703-7. PubMed ID: 20485441
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury in mice.
Sakashita A; Nishimura Y; Nishiuma T; Takenaka K; Kobayashi K; Kotani Y; Yokoyama M
Eur J Pharmacol; 2007 Sep; 571(1):62-71. PubMed ID: 17599828
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil elastase inhibitors as treatment for COPD.
Ohbayashi H
Expert Opin Investig Drugs; 2002 Jul; 11(7):965-80. PubMed ID: 12084007
[TBL] [Abstract][Full Text] [Related]
15. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
16. Effect of a neutrophil elastase inhibitor on acute lung injury after cardiopulmonary bypass.
Fujii M; Miyagi Y; Bessho R; Nitta T; Ochi M; Shimizu K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):859-62. PubMed ID: 20354035
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil elastase inhibitors: recent advances in the development of mechanism-based and nonelectrophilic inhibitors.
Sjö P
Future Med Chem; 2012 Apr; 4(5):651-60. PubMed ID: 22458683
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of a selective neutrophil elastase inhibitor (sivelestat) on lipopolysaccharide-induced acute dysfunction of the pulmonary microcirculation.
Inoue Y; Seiyama A; Tanaka H; Ukai I; Akimau P; Nishino M; Shimazu T; Sugimoto H
Crit Care Med; 2005 Aug; 33(8):1814-22. PubMed ID: 16096460
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil elastase inhibitors: a patent review and potential applications for inflammatory lung diseases (2010 - 2014).
Tsai YF; Hwang TL
Expert Opin Ther Pat; 2015; 25(10):1145-58. PubMed ID: 26118988
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil elastase inhibitor improves survival rate after ischemia reperfusion injury caused by supravisceral aortic clamping in rats.
Fujimura N; Obara H; Suda K; Takeuchi H; Miyasho T; Kawasako K; Du W; Yamada S; Ono S; Matsumoto K; Matsuda S; Yagi H; Kitago M; Shinoda M; Itano O; Tanabe M; Sakamoto M; Maruyama I; Kitagawa Y
J Surg Res; 2013 Mar; 180(1):e31-6. PubMed ID: 22595015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
